In mid-2021, after a decade of R&D, Neuralace Medical earned FDA clearance for its Axon Therapy, a noninvasive treatment option for chronic pain caused by nerve damage. The road to its next regulatory ...
Non-Invasive Magnetic Peripheral Nerve Stimulation (mPNS) Treatment Offers New Hope for PDN Patients SAN DIEGO, Jan. 11, 2024 /PRNewswire/ -- Neuralace Medical, Inc., an innovator in pain management ...
New Generation Software Expected to Drive Best-In-Class Radiosurgery Brain Tumor Treatments ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced the ...
REBALANCE-HF early feasibility trial met objective of identifying responder group with demonstrated benefits in heart function, hemodynamics, and physical activity at 6 months SAVM procedure quick and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback